Nuclear Translocation of Heme Oxygenase-1 Confers Resistance to Imatinib in Chronic Myeloid Leukemia Cells

E-ISSN： 1873-4286|19|15|2765-2770

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.15, 2013-03, pp. : 2765-2770

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of chronic myeloid leukemia when imatinib fails

By Hehlmann Rüdiger Jung-Munkwitz Susanne Saußele Susanne

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 269-283

Informa Healthcare

Access to resources Recommend Favorite

Imatinib: Development of resistance in chronic myeloid leukaemia: case report

Reactions Weekly, Vol. 1, Iss. 1432, 2012-01 ,pp. : 27-28

Adis International

Access to resources Recommend Favorite

Inducers of Heme Oxygenase-1

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 473-486

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitor Resistance and Epigenetic Regulation of SHP1 Phosphatase Expression in Chronic Myeloid Leukemia

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 4, 2014-12 ,pp. : 240-249

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of heme oxygenase-1 by endothelial cells: a protective response to injury in transplantation

By Soares M. Brouard S. Smith R. Otterbein L. Choi A. Bach F.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 11-27

Informa Healthcare

Access to resources Recommend Favorite